Skip to content

Cord Blood Nesfatin-1 and Irisin in the Intrauterine Growth Restricted Fetuses

The Association of Cord Blood Nesfatin-1 and Irisin Level With Fetal Doppler Parameters in Pregnancies Complicated With Intrauterine Growth Restricted Fetuses

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03808571
Enrollment
66
Registered
2019-01-17
Start date
2018-01-01
Completion date
2019-01-15
Last updated
2019-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intrauterine Growth Restriction, Irisin, Nesfatin-1

Brief summary

: The aim of this study is to investigate Cord blood irisin and nesfatin-1 levels in pregnancies with intrauterine growth retardation and to determine whether they are associated with abnormal fetal doppler findings or not.

Detailed description

This study was conducted at Yüzüncü Yıl University Medical Faculty Obstetrics and Gynecology Clinic. The study group included 34 pregnant women ranged from 18 to 45 years old who have intrauterine growth retardation and underwent ceseraen section. 32 pregnant women who had no abnormality on prenatal follow-up and underwent elective ceserean seciton served as control group. The maternal age, height, weight, body mass index (BMI), systolic and diastolic blood pressures were recorded in both groups of patients. Maternal serum total blood count and biochemical parameters were obtained from the laboratory parameters. Gestational week at birth, birth weight, sex, 1st and 5th minute APGAR scores were recorded. Blood samples were collected from all the cases during the cesarean section for measurmenet of nesfatin-1 and irisin by doubly clamped umbilical cord. Blood samples were immediately centrifuged in sterile tubes and maintained at -80 ° C until assessed.

Interventions

OTHERcord blood specimen during the delivery

The cord blood will be taken during the delivery of baby.

Sponsors

Yuzuncu Yil University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years

Inclusion criteria

* Pregnant women with intrauterine grwoth rectricted fetuses. * Healthy pregnancies

Exclusion criteria

* Pregnant women with chronic medical conditions * multiple pregnancies * fetuses with fetal malfomations or genetic syndromes * pregnant women older than 45 years old

Design outcomes

Primary

MeasureTime frameDescription
cord blood nesfatn-1 level measurement9 monthscord blood levels of nesfatin-1 in pregnancies with intrauterine growth restricted fetuses and healthy pregnancies.

Secondary

MeasureTime frameDescription
Cord blood irisin level measurement9 monthsord blood levels of irisin in pregnancies with intrauterine growth restricted fetuses and healthy pregnancies.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026